13F Holdings
中文EN

LAKE LAKELAND INDUSTRIES INC

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 798081 · Fiscal year ends 01/31

Financial factors as of 2026-07-31 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-0.3%
TTM net income YoY-24.3%
TTM EPS YoY1.4%
Revenue 3-yr CAGR17.0%
Net income 3-yr CAGR—

Margins

Gross margin32.6%
Operating margin-4.1%
Net margin-14.0%
FCF margin-0.3%
EBITDA margin-2.5%

Returns

ROE-19.6%
ROA-12.3%
ROIC (approx.)-4.7%
Asset turnover0.88x

Leverage & solvency

Liabilities / assets39.4%
Debt / equity0.23x
Current ratio2.98x
Interest coverage-3.50x

Cash quality & payout

Operating cash flow / net income0.03x
Accruals ratio-12.0%
Payout ratio—
Capex / revenue-0.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-01-31FY20252025-01-31FY20252024-04-30FY20242024-01-31FY20242023-04-30
Income statement
Revenue$192.65M$167.21M$6.30M$124.69M$6.00M
Cost of revenue$129.32M$98.54M—$73.50M—
Gross profit$63.33M$68.67M—$51.19M—
Operating income-$15.51M-$9.27M—$5.99M—
Interest expense$2.15M$1.65M—$52,000—
Pretax income-$17.70M-$18.36M—$9.36M—
Income tax$7.61M-$281,000—$3.93M—
Net income-$25.31M-$18.07M—$5.42M—
EBITDA-$12.71M-$6.67M—$7.89M—
EPS (basic)-2.63-2.43—0.74—
EPS (diluted)-2.63-2.43—0.72—
Weighted avg. shares (diluted)9.63M7.43M—7.54M—
Balance sheet
Cash & equivalents$12.52M$17.48M$28.36M$25.22M$26.02M
Short-term investments———$2.16M—
Receivables$32.04M$27.61M$21.76M$19.20M$16.86M
Inventory$82.54M$82.74M$56.06M$51.25M$57.90M
Current assets$134.19M$136.53M$113.77M$101.50M$107.94M
PP&E, net$11.64M$13.95M$11.93M$10.69M$9.22M
Goodwill$15.29M$16.24M$15.21M$13.67M$8.47M
Intangibles$31.72M$25.50M$7.92M$6.83M$5.94M
Total assets$209.93M$212.53M$171.52M$153.75M$145.09M
Current liabilities$37.96M$34.91M$21.10M$18.35M$20.53M
Short-term debt$1.89M$939,000$0$298,000$115,000
Long-term debt$30.38M$16.43M———
Total debt$32.27M$17.36M———
Total liabilities$80.81M$65.91M$46.41M$30.29M$24.96M
Shareholders' equity$129.13M$146.63M$125.11M$123.45M$120.14M
Net debt$19.76M-$111,000———
Shares outstanding9.81M9.50M7.38M7.36M7.36M
Cash flow statement
Operating cash flow-$15.75M-$15.88M—$10.91M—
Capital expenditure$671,000$1.54M—$2.07M—
Free cash flow-$16.42M-$17.42M—$8.84M—
Investing cash flow-$1.18M-$47.74M—-$5.12M—
Financing cash flow$12.51M$56.59M—-$3.45M—
Depreciation & amortization$2.80M$2.60M—$1.90M—
Stock-based compensation$3.39M$1.56M—$1.36M—
Dividends paid$1.15M$887,000—$908,000—

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.